Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CytRx Corp (NASDAQ:CYTR)

0.407
Delayed Data
As of 10:57am ET
 -0.013 / -3.10%
Today’s Change
0.36
Today|||52-Week Range
3.66
+9.35%
Year-to-Date
No recent news for CytRx Corp.

Today’s Trading

Previous close0.42
Today’s open0.42
Day’s range0.41 - 0.42
Volume261,342
Average volume (3 months)1,243,036
Market cap$48.9M
Dividend yield--
Data as of 10:57am ET, 01/24/2017

Growth & Valuation

Earnings growth (last year)-76.36%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,602.80
Price/Book0.63

Competitors

 Today’s
change
Today’s
% change
PLXProtalix Biotherapeu...+0.02+4.51%
KMPHKemPharm Inc-0.05-1.52%
APVOAptevo Therapeutics ...-0.10-4.35%
CURNeuralstem Inc-0.09-2.59%
Data as of 10:57am ET, 01/24/2017

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$100.0K
Annual profit (last year)-$58.6M
Net profit margin-58,587.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Steven A. Kriegsman
Chief Operating &
Medical Officer
Daniel J. Levitt
Corporate headquarters
Los Angeles, California

Forecasts


Search for Jobs